作者:Atul Goel、Sharlyn J. Mazur、Rasem J. Fattah、Tracy L. Hartman、Jim A. Turpin、Mingjun Huang、William G. Rice、Ettore Appella、John K. Inman
DOI:10.1016/s0960-894x(02)00007-0
日期:2002.3
The HIV-1 nucleocapsid protein NCp7, which contains two highly conserved zinc fingers, is being used as a novel target for AIDS therapy due to its pivotal role in viral replication and its mutationally intolerant nature. Herein we report a new class of NCp7 inhibitors that possess good antiviral activity with low cellular toxicity.
HIV-1核衣壳蛋白NCp7包含两个高度保守的锌指,由于其在病毒复制中起关键作用并且具有突变耐受性,因此被用作AIDS治疗的新靶标。在本文中,我们报告了一类新的具有良好抗病毒活性和低细胞毒性的NCp7抑制剂。